Mesenchymal Stem Cell Conditioning Promotes Rat Oligodendroglial Cell Maturation
Open Access
- 12 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e71814
Abstract
Oligodendroglial progenitor/precursor cells (OPCs) represent the main cellular source for the generation of new myelinating oligodendrocytes in the adult central nervous system (CNS). In demyelinating diseases such as multiple sclerosis (MS) myelin repair activities based on recruitment, activation and differentiation of resident OPCs can be observed. However, the overall degree of successful remyelination is limited and the existence of an MS-derived anti-oligodendrogenic milieu prevents OPCs from contributing to myelin repair. It is therefore of considerable interest to understand oligodendroglial homeostasis and maturation processes in order to enable the development of remyelination therapies. Mesenchymal stem cells (MSC) have been shown to exert positive immunomodulatory effects, reduce demyelination, increase neuroprotection and to promote adult neural stem cell differentiation towards the oligodendroglial lineage. We here addressed whether MSC secreted factors can boost the OPC’s oligodendrogenic capacity in a myelin non-permissive environment. To this end, we analyzed cellular morphologies, expression and regulation of key factors involved in oligodendroglial fate and maturation of primary rat cells upon incubation with MSC-conditioned medium. This demonstrated that MSC-derived soluble factors promote and accelerate oligodendroglial differentiation, even under astrocytic endorsing conditions. Accelerated maturation resulted in elevated levels of myelin expression, reduced glial fibrillary acidic protein expression and was accompanied by downregulation of prominent inhibitory differentiation factors such as Id2 and Id4. We thus conclude that apart from their suggested application as potential anti-inflammatory and immunomodulatory MS treatment, these cells might also be exploited to support endogenous myelin repair activities.Keywords
This publication has 28 references indexed in Scilit:
- Success of immunomodulators in MS shifts discovery focus to neuroprotectionNature Reviews Drug Discovery, 2011
- The complex world of oligodendroglial differentiation inhibitorsAnnals of Neurology, 2011
- Enhancing remyelination in disease--can we wrap it up?Brain, 2011
- Neuroprotective features of mesenchymal stem cellsBest Practice & Research Clinical Haematology, 2011
- Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune EncephalomyelitisJournal of Neuropathology & Experimental Neurology, 2010
- Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosisTrends in Neurosciences, 2010
- Mesenchymal Stem Cells Instruct Oligodendrogenic Fate Decision on Adult Neural Stem CellsStem Cells, 2006
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis LesionsThe Journal of Neuroscience, 2000
- Bone Morphogenetic Proteins Induce Astroglial Differentiation of Oligodendroglial–Astroglial Progenitor CellsThe Journal of Neuroscience, 1997